Hodgkin’s Lymphoma also known as Hodgkin’s disease is a type of blood cancer that initiate in the lymphatic system (part of immune system that help to get rid of waste and fight against infections). This disease is the most common type of cancer of lymphatic system. Hodgkin disease originate in the WBCs and grow abnormally and spread beyond the lymphatic system. As the disease progress it invades into other organs and can damage their function. Hodgkin’s lymphoma are more common in men than women and affect individuals between the age of 15-40 and above 55 years. The exact etiology of Hodgkin’s Lymphoma is not clear however, DNA mutation, and infection of Epstein-Barr virus (EBV), which causes mononucleosis can be the reason behind the development of Hodgkin’s lymphoma.
DelveInsight’s, “Hodgkin’s Lymphoma Pipeline Insight, 2021” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hodgkin’s Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/hodgkins-lymphoma-pipeline-insight
Hodgkin’s Lymphoma Key Players
- Affimed Therapeutics
- ACD Therapeutics
- Cstone Pharmaceuticals
- 4SC
- TG Therapeutics
- And Many Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/hodgkins-lymphoma-pipeline-insight
DelveInsight’s Hodgkin’s Lymphoma report covers around 10+ products under different phases of clinical development like
- Mid-stage products (Phase II and Phase I/II)
- Early-stage products (Phase I/II and Phase I) along with the details of
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Some of Hodgkin’s Lymphoma Therapies are:
- AFM 13
- Camidanlumab tesirine
- Sugemalimab
- Resminostat
- TGR-1202
- And Many Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/hodgkins-lymphoma-pipeline-insight
Current Hodgkin’s Lymphoma Treatment Scenario and Hodgkin’s Lymphoma Emerging Therapies:
- How many companies are developing Hodgkin’s Lymphoma drugs?
- How many Hodgkin’s Lymphoma drugs are developed by each company?
- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Hodgkin’s Lymphoma?
- What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Hodgkin’s Lymphoma therapeutics?
- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Hodgkin’s Lymphoma and their status?
- What are the key designations that have been granted to the emerging drugs?
Request for Free Sample Report: https://www.delveinsight.com/sample-request/hodgkins-lymphoma-pipeline-insight
Table of Contents:
Introduction
Executive Summary
Hodgkin’s Lymphoma: Overview
- Causes
- Mechanism of Action
- Signs and Symptoms
- Diagnosis
- Disease Management
Pipeline Therapeutics
- Comparative Analysis
Therapeutic Assessment
- Assessment by Product Type
- Assessment by Stage and Product Type
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
Hodgkin’s Lymphoma – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
- Hodgkin’s Lymphoma companies’ collaborations, Licensing, Acquisition -Deal Value Trends
Hodgkin’s Lymphoma Collaboration Deals
- Company-Company Collaborations (Licensing / Partnering) Analysis
- Company-University Collaborations (Licensing / Partnering) Analysis
Mid Stage Products (Phase II)
- Comparative Analysis
AFM 13:Affimed Therapeutics
- Product Description
- Research and Development
- Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
- Comparative Analysis
Camidanlumab tesirine: ACD Therapeutics
- Product Description
- Research and Development
- Product Development Activities
Drug profiles in the detailed report…..
Pre-clinical and Discovery Stage Products
- Comparative Analysis
- Product Description
- Research and Development
- Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
- Comparative Analysis
Hodgkin’s Lymphoma Key Companies
Hodgkin’s Lymphoma Key Products
Hodgkin’s Lymphoma- Unmet Needs
Hodgkin’s Lymphoma- Market Drivers and Barriers
Hodgkin’s Lymphoma- Future Perspectives and Conclusion
Hodgkin’s Lymphoma Analyst Views
Hodgkin’s Lymphoma Key Companies
Appendix
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/hodgkins-lymphoma-pipeline-insight